Loading...
Loncar China BioPharma ETF
CHNA•NASDAQ
Financial ServicesAsset Management
$13.53
$-0.01(-0.07%)
Loncar China BioPharma ETF (CHNA) Stock Overview
Explore Loncar China BioPharma ETF’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for CHNAStats details for CHNA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for CHNAAnalyst Recommendations details for CHNA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
Headquarters
DE
Founded
2018